Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.71 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.71 |
| ▸ | TYR | P14679 | 3/20 | 0.71 |
| ▸ | TP53 | P04637 | 2/20 | 0.71 |
| ▸ | MAPT | P10636 | 2/20 | 0.71 |
| ▸ | MEN1 | O00255 | 1/20 | 0.71 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.71 |
| ▸ | TSHR | P16473 | 1/20 | 0.71 |
| ▸ | HTT | P42858 | 1/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.71 |
| ▸ | PTGS2 | P35354 | 7/20 | 0.53 |
| ▸ | ESR1 | P03372 | 2/20 | 0.53 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.53 |
| ▸ | TACR2 | P21452 | 2/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10432808 | 1.00 | CYP3A4 (0.71) | CYP3A4ALOX5TYRTP53MAPT | |
| SCHEMBL28227727 | 1.00 | CYP3A4 (0.71) | CYP3A4ALOX5TYRTP53MAPT | |
| SCHEMBL18704820 | 1.00 | CYP3A4 (0.71) | CYP3A4ALOX5TYRTP53MAPT | |
| SCHEMBL15542126 | 1.00 | CYP3A4 (0.71) | CYP3A4ALOX5TYRTP53MAPT | |
| SCHEMBL31553267 | 1.00 | CYP3A4 (0.71) | CYP3A4ALOX5TYRTP53MAPT | |
| SCHEMBL31553270 | 1.00 | CYP3A4 (0.71) | CYP3A4ALOX5TYRTP53MAPT | |
| SCHEMBL18704826 | 1.00 | CYP3A4 (0.71) | CYP3A4ALOX5TYRTP53MAPT | |
| SCHEMBL3963871 | 0.98 | CYP3A4 (0.68) | CYP3A4ALOX5TYRTP53MAPT | |
| SCHEMBL330111 | 0.92 | TYR (0.69) | CYP3A4ALOX5TYRTP53MAPT | |
| SCHEMBL31553269 | 0.92 | TYR (0.69) | CYP3A4ALOX5TYRTP53MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3359596-B1 | PHOSPHATE ESTER COMPOSITION AND USE | SASOL USA CORP (US) | 2025-05-07 | — | — | EP | claimed |
| CN-108291053-B | Phosphate ester composition and use | 萨索尔（美国）公司 | 2020-10-16 | — | — | CN | claimed |
| US-10544173-B2 | Phosphate ester composition and use | SASOL (USA) CORPORATION (US) | 2020-01-28 | — | — | US | claimed |
| US-20180273556-A1 | Phosphate Ester Composition and Use | SASOL USA CORP (US) | 2018-09-27 | — | — | US | claimed |
| CN-108291053-A | Phosphate-ester composition and purposes | 萨索尔（美国）公司 | 2018-07-17 | — | — | CN | claimed |
| WO-2017062557-A1 | PHOSPHATE ESTER COMPOSITION AND USE | SASOL (USA) CORPORATION (US) | 2017-04-13 | — | — | WO | claimed |
| EP-3359596-B1 | PHOSPHATE ESTER COMPOSITION AND USE | SASOL USA CORP (US) | 2025-05-07 | — | — | EP | disclosed |
| CN-108291053-B | Phosphate ester composition and use | 萨索尔（美国）公司 | 2020-10-16 | — | — | CN | disclosed |
| US-10544173-B2 | Phosphate ester composition and use | SASOL (USA) CORPORATION (US) | 2020-01-28 | — | — | US | disclosed |
| US-20180273556-A1 | Phosphate Ester Composition and Use | SASOL USA CORP (US) | 2018-09-27 | — | — | US | disclosed |
| CN-108291053-A | Phosphate-ester composition and purposes | 萨索尔（美国）公司 | 2018-07-17 | — | — | CN | disclosed |
| WO-2017062557-A1 | PHOSPHATE ESTER COMPOSITION AND USE | SASOL (USA) CORPORATION (US) | 2017-04-13 | — | — | WO | disclosed |
| EP-0318941-B1 | DEVELOPER FOR PRESSURE-SENSITIVE RECORDING SHEETS, AQUEOUS DISPERSION OF THE DEVELOPER AND METHOD FOR PREPARING THE DEVELOPER | Sanko Kaihatsu Kagaku Kenkyusho (JP) | 1993-06-09 | — | — | EP | disclosed |
| US-5118443-A | DEVELOPER FOR PRESSURE-SENSITIVE RECORDING SHEETS, AQUEOUS DISPERSION OF THE DEVELOPER AND METHOD FOR PREPARING THE DEVELOPER | SANKO KAIHATSU KAGAKU KENKYUSHO (JP) | 1992-06-02 | — | — | US | disclosed |
| EP-0318941-A2 | Developer for pressure-sensitive recording sheets, aqueous dispersion of the developer and method for preparing the developer | Sanko Kaihatsu Kagaku Kenkyusho (JP) | 1989-06-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180273556-A1 | Phosphate Ester Composition and Use | PFKFB2, F12, PFKFB1 | CYP3A4 1080/4885ALOX5 940/4885TYR 2569/4885 |
| US-10544173-B2 | Phosphate ester composition and use | PFKFB2, F12, PFKFB1 | CYP3A4 1080/4885ALOX5 940/4885TYR 2569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.